Xenon Pharmaceuticals to Present at TD Cowen’s 3rd Annual Novel Mechanisms in Neuropsychiatry Summit
2023年9月15日 - 5:01AM
Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused
biopharmaceutical company, today announced that the company will
present at TD Cowen’s 3rd Annual Novel Mechanisms in
Neuropsychiatry Summit to be held on September 20, 2023.
Company Fireside Chat Presentation
Details: |
|
|
Date: |
Wednesday, September 20, 2023 |
|
|
Time: |
4:20 pm Eastern Time |
|
|
Webcast: |
Register here |
|
|
Presenters: |
Ian Mortimer, President and Chief Executive OfficerSherry
Aulin, Chief Financial Officer |
|
|
A live webcast of the company presentation will
be available on the “Investors” section of Xenon's website and
posted for replay following the event. The above listed dates and
times are subject to change.
About Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals (NASDAQ:XENE) is a
clinical stage biopharmaceutical company committed to developing
innovative therapeutics to improve the lives of patients with
neurological disorders. We are advancing a novel product pipeline
of neurology therapies to address areas of high unmet medical need,
with a focus on epilepsy. For more information, please visit
www.xenon-pharma.com.
“Xenon” and the Xenon logo are registered
trademarks or trademarks of Xenon Pharmaceuticals Inc. in various
jurisdictions. All other trademarks belong to their respective
owner.
Investor/Media Contact:Jodi RegtsXenon
Pharmaceuticals Inc.Phone: 604.484.3353Email:
investors@xenon-pharma.com
Xenon Pharmaceuticals (NASDAQ:XENE)
過去 株価チャート
から 5 2024 まで 6 2024
Xenon Pharmaceuticals (NASDAQ:XENE)
過去 株価チャート
から 6 2023 まで 6 2024